COVID-19: breaking down a global health crisis

SI Mallah, OK Ghorab, S Al-Salmi, OS Abdellatif… - Annals of clinical …, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) is the second pandemic of the twenty-first
century, with over one-hundred million infections and over two million deaths to date. It is a …

Current advances in the classification, production, properties and applications of microbial biosurfactants–A critical review

A Kashif, R Rehman, A Fuwad, MK Shahid… - Advances in Colloid and …, 2022 - Elsevier
This review discusses the classification, characteristics, and applications of biosurfactants.
The biosynthesis pathways for different classes of biosurfactants are reviewed. An in-depth …

Glycyrrhizin: An alternative drug for the treatment of COVID-19 infection and the associated respiratory syndrome?

C Bailly, G Vergoten - Pharmacology & therapeutics, 2020 - Elsevier
Safe and efficient drugs to combat the current COVID-19 pandemic are urgently needed. In
this context, we have analyzed the anti-coronavirus potential of the natural product …

COVID-19: Advances in diagnostic tools, treatment strategies, and vaccine development

M Sreepadmanabh, AK Sahu, A Chande - Journal of biosciences, 2020 - Springer
An unprecedented worldwide spread of the SARS-CoV-2 has imposed severe challenges
on healthcare facilities and medical infrastructure. The global research community faces …

Short-Term Effects of Ambient Ozone, PM2.5, and Meteorological Factors on COVID-19 Confirmed Cases and Deaths in Queens, New York

A Adhikari, J Yin - International journal of environmental research and …, 2020 - mdpi.com
The outbreak of coronavirus disease 2019 (COVID-19), caused by the virus SARS-CoV-2,
has been rapidly increasing in the United States. Boroughs of New York City, including …

[HTML][HTML] Mutated COVID-19 may foretell a great risk for mankind in the future

AA Dawood - New microbes and new infections, 2020 - Elsevier
Abstract Coronavirus disease 2019 SARS-CoV-2 (COVID-19) is a zoonotic virus causing a
variety of severe respiratory diseases. SARS-CoV-2 is closest to SARS-CoV and MERS-CoV …

Cholesterol in relation to COVID-19: should we care about it?

D Radenkovic, S Chawla, M Pirro, A Sahebkar… - Journal of clinical …, 2020 - mdpi.com
Current data suggest that infection with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) causing corona virus disease-19 (COVID-19) seems to follow a more severe …

Cholesterol, lipoproteins, and COVID-19: Basic concepts and clinical applications

E Kočar, T Režen, D Rozman - … et Biophysica Acta (BBA)-Molecular and …, 2021 - Elsevier
Cholesterol is being recognized as a molecule involved in regulating the entry of the SARS-
CoV-2 virus into the host cell. However, the data about the possible role of cholesterol …

Dissecting lipid metabolism alterations in SARS-CoV-2

I Casari, M Manfredi, P Metharom, M Falasca - Progress in lipid research, 2021 - Elsevier
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the cause of the COVID-
19 pandemic that has infected over a hundred million people globally. There have been …

Potential therapeutic targets and vaccine development for SARS-CoV-2/COVID-19 pandemic management: a review on the recent update

U Anand, S Jakhmola, O Indari, HC Jha… - Frontiers in …, 2021 - frontiersin.org
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) is a highly pathogenic
novel virus that has caused a massive pandemic called coronavirus disease 2019 (COVID …